Cargando…

The diagnostic utility of inmunohistochemical and electronic microscopy in distinguishing between pleural mesothelioma and adenocarcinoma

Detalles Bibliográficos
Autores principales:	Carrillo C, Carlos González, Malagón, Hugo Dominguez, Arrieta, Oscar
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796577/ http://dx.doi.org/10.1186/1471-2407-7-S1-A32

Ejemplares similares

Inmunohistochemical Profile of Solid Cell Nest of Thyroid Gland
por: Ríos Moreno, María José, et al.
Publicado: (2011)

Diagnostic Challenges in Epithelioid Pleural Mesothelioma: Case Series with Support from Electron Microscopy
por: Fortarezza, Francesco, et al.
Publicado: (2021)

Inmunohistochemical detection of mastocytes in tissue from patients with actinic prurigo
por: Martínez-Luna, Eduwiges, et al.
Publicado: (2015)

Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma
por: Gayosso-Gómez, LV, et al.
Publicado: (2014)

A Method for Unsupervised Semi-Quantification of Inmunohistochemical Staining with Beta Divergences
por: Sarmiento, Auxiliadora, et al.
Publicado: (2022)

Inmunohistochemical detection of pandemic SARS-CoV-2 antigens in lung tissue
por: Rivera, Jorge, et al.
Publicado: (2022)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma from lung cancer using pleural carcinoembryonic antigen and hyaluronic acid levels
por: Saraya, Takeshi, et al.
Publicado: (2022)

Diagnostic imaging and workup of malignant pleural mesothelioma
por: Cardinale, Luciano, et al.
Publicado: (2017)

Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
por: Dipper, Alex, et al.
Publicado: (2021)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022)

Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
por: Schillebeeckx, Eline, et al.
Publicado: (2021)

Locoregional control and toxicity after pleurectomy/decortication and intensity‐modulated pleural radiation therapy in patients with malignant pleural mesothelioma
por: Arrieta, Oscar, et al.
Publicado: (2020)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Biodistribution and Tumor Uptake of (67)Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft
por: Izquierdo-Sánchez, Vanessa, et al.
Publicado: (2018)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
por: Halimi, Monireh, et al.
Publicado: (2019)

Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man
por: Ibnian, Ali M., et al.
Publicado: (2023)

Clinical significance of histologic subtyping of malignant pleural mesothelioma
por: Brcic, Luka, et al.
Publicado: (2020)

Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
por: Pei, Dongxu, et al.
Publicado: (2017)

Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report
por: Yamazoe, Masatoshi, et al.
Publicado: (2018)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma
por: Kahlos, K, et al.
Publicado: (2000)

Widespread pulmonary invasion by malignant pleural mesothelioma: an important diagnostic consideration
por: MacMillan, Mia, et al.
Publicado: (2020)

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma
por: Watanabe, Masayuki, et al.
Publicado: (2021)

Serum diagnostic markers for malignant pleural mesothelioma: a narrative review
por: Wang, Jing-Jing, et al.
Publicado: (2022)

Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
por: Hjerpe, Anders, et al.
Publicado: (2020)

Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
por: Pei, Dongxu, et al.
Publicado: (2018)

The diagnostic utility of pleural markers for tuberculosis pleural effusion
por: Zhang, Man, et al.
Publicado: (2020)

Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma
por: Masiuk, Marek, et al.
Publicado: (2020)

Genomics of Tumor Origin and Characteristics for Adenocarcinoma and Malignant Pleural Mesothelioma: A Case Report
por: Usuda, Katsuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36v4grvnflblduak55klkf25po